Inventor · disambiguated record
Kalyani Penta
Also filed as: PENTA KALYANI
11 granted patents·6 pending applications·56 citations·filing 2009–2025
89Inventor score
Top patents by PatentIndex Score
17 records- 0194US9764039B2Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2014·Granted Sep 19, 2017·20 cites·36 claims
- 0292US10669347B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·5 cites·16 claims
- 0392US9738724B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 22, 2017·12 cites·35 claims
- 0491US9732161B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 15, 2017·7 cites·20 claims
- 0588US10501558B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·20 claims
- 0683US11958909B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2020·Granted Apr 16, 2024·1 cites·20 claims
- 0783US2025002604A1Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0882US11708413B2Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2017·Granted Jul 25, 2023·3 cites·29 claims
- 0980US8324165B2Compositions for treating arthritis comprising HG1023575 polypeptidePENTA KALYANI·Filed 2009·Granted Dec 4, 2012·4 cites·3 claims
- 1074US2025304723A1Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1172US12252552B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2019·Granted Mar 18, 2025·0 cites·32 claims
- 1272US2023114070A1Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1371US10975150B2Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodiesSUTRO BIOPHARMA INC·Filed 2015·Granted Apr 13, 2021·1 cites·29 claims
- 1471US2024182580A1Anti-cd74 antibody conjugates, compositions comprising anti cd74 antibody conjugates and methods of using anti-cd74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1569US2025236674A9Anti-cd74 antibody conjugates, compositions comprising anti cd74 antibody conjugates and methods of using anti-cd74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1662US11344626B2Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted May 31, 2022·0 cites·39 claims
- 1761US2021284739A1Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodiesSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kalyani Penta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →